Clopidogrel(TM): an alternative to acetylsalicylic acid and ticlopidine in antiplatelet therapy?
Shukla
V
V
D001161:Arteriosclerosis / Q000150:complications / Q000188:drug therapy; D002170:Canada; D003362:Cost-Benefit Analysis; D004341:Drug Evaluation; D006331:Heart Diseases / Q000188:drug therapy*; D006801:Humans; D002546:Ischemic Attack, Transient / Q000188:drug therapy*; D010975:Platelet Aggregation Inhibitors / Q000191:economics / Q000627:therapeutic use*; D013988:Ticlopidine / Q000191:economics / Q000627:therapeutic use*
D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine